Bliss GVS Pharma Shareholding Pattern & Promoter Holding
· Latest pattern: Sep 2026
As of Sep 2026, promoters hold 50.07% of Bliss GVS Pharma, FIIs hold 5.03%, DIIs hold 9.62% and the public holds 35.29%. Promoter holding rose by 15.06 percentage points from Jun 2026.
Get an alert when Bliss GVS Pharma reports results or its shareholding changes. Free account.
Promoters
50.07%
+15.06 pp QoQ
FIIs
5.03%
−3.04 pp QoQ
DIIs
9.62%
+0.16 pp QoQ
Public
35.29%
−12.16 pp QoQ
Bliss GVS Pharma shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 50.07% | 5.03% | 9.62% | 35.29% | 47,944 |
| Jun 2026 | 35.01% | 8.07% | 9.46% | 47.45% | 46,767 |
| Mar 2026 | 35.36% | 10.45% | 5.04% | 49.15% | 44,874 |
| Dec 2025 | 35.36% | 14.54% | 5.78% | 44.32% | 43,380 |
| Sep 2025 | 35.39% | 13.27% | 5.98% | 45.36% | 44,461 |
| Jun 2025 | 35.44% | 12.65% | 6.54% | 45.37% | 46,707 |
| Mar 2025 | 35.29% | 13.18% | 6.55% | 44.98% | 49,517 |
| Dec 2024 | 35.10% | 13.51% | 6.55% | 44.84% | 49,558 |
| Sep 2024 | 34.82% | 12.13% | 6.56% | 46.49% | 52,937 |
| Jun 2024 | 34.90% | 13.24% | 6.58% | 45.27% | 44,737 |
| Mar 2024 | 34.97% | 14.74% | 6.59% | 43.71% | 45,157 |
| Dec 2023 | 34.97% | 15.35% | 6.60% | 43.08% | 40,758 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹7.29k cr, the promoter group's 50.07% stake is worth ₹3.65k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in peers
Bliss GVS Pharma shareholding: common questions
What is the promoter holding in Bliss GVS Pharma?
Promoters hold 50.07% of Bliss GVS Pharma as of Sep 2026. Their stake rose by 15.06 percentage points from Jun 2026.
How much do FIIs hold in Bliss GVS Pharma?
Foreign institutional investors (FIIs) held 5.03% of Bliss GVS Pharma in Sep 2026, −3.04 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Bliss GVS Pharma?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 9.62% of Bliss GVS Pharma in Sep 2026, +0.16 pp versus Jun 2026.
Is the promoter holding in Bliss GVS Pharma pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Bliss GVS Pharma.
How has Bliss GVS Pharma's promoter holding changed in the last year?
Promoter holding moved from 35.39% in Sep 2025 to 50.07% in Sep 2026 (+14.68 pp).
How many shareholders does Bliss GVS Pharma have?
Bliss GVS Pharma had 47,944 shareholders in Sep 2026, compared with 46,767 in Jun 2026.